筹码集中
Search documents
万丰股份最新筹码趋于集中
Zheng Quan Shi Bao Wang· 2025-09-24 08:34
Core Points - WanFeng Co., Ltd. reported a decrease in the number of shareholders to 8,043 as of September 20, down by 571 from the previous period, representing a decline of 6.63% [2] - The closing price of WanFeng shares was 17.15 yuan, reflecting an increase of 3.56%, although the stock has seen a cumulative decline of 1.49% since the concentration of shares began [2] - The latest margin trading data shows a total margin balance of 25.40 million yuan, with a financing balance of 25.40 million yuan, indicating a reduction of 1.96 million yuan, or 7.15%, during the current period of concentrated shareholding [2] - The company's semi-annual report indicated that it achieved operating revenue of 275 million yuan, a year-on-year increase of 17.33%, and a net profit of 25.14 million yuan, a year-on-year increase of 91.69%, with basic earnings per share of 0.1900 yuan and a weighted average return on equity of 2.38% [2]
光智科技最新股东户数环比下降7.69% 筹码趋向集中
Zheng Quan Shi Bao Wang· 2025-09-24 06:27
Group 1 - The core point of the article highlights that Guangzhi Technology has experienced a decrease in the number of shareholders, with a reduction of 2,000 shareholders to a total of 24,000, representing a 7.69% decline compared to the previous period [2] - The latest stock price of Guangzhi Technology is reported at 45.98 yuan, reflecting a 1.03% increase, although the stock has cumulatively decreased by 8.17% since the concentration of shares began [2] - The company's semi-annual report indicates that it achieved a revenue of 1.02 billion yuan in the first half of the year, marking a year-on-year growth of 78.20%, and a net profit of 23.99 million yuan, which is a 167.77% increase compared to the previous year [2]
科华数据最新股东户数环比下降9.33% 筹码趋向集中
Zheng Quan Shi Bao Wang· 2025-09-24 04:56
融资融券数据显示,该股最新(9月23日)两融余额为23.04亿元,其中,融资余额为22.98亿元,本期筹 码集中以来融资余额合计增加6.62亿元,增幅为40.48%。 公司发布的半年报数据显示,上半年公司共实现营业收入37.33亿元,同比增长0.06%,实现净利润2.44 亿元,同比增长7.94%,基本每股收益为0.5100元,加权平均净资产收益率5.08%。 机构评级来看,近一个月该股获8家机构买入评级。预计目标价最高的是中金公司,8月31日中金公司发 布的研报给予公司目标价70.00元。(数据宝) 科华数据9月24日披露,截至9月20日公司股东户数为68000户,较上期(9月10日)减少7000户,环比降 幅为9.33%。 证券时报·数据宝统计,截至发稿,科华数据最新股价为73.50元,下跌3.38%,本期筹码集中以来股价 累计上涨28.83%。具体到各交易日,6次上涨,4次下跌,其中,涨停2次。 注:本文系新闻报道,不构成投资建议,股市有风险,投资需谨慎。 (文章来源:证券时报网) ...
万安科技最新股东户数环比下降7.38% 筹码趋向集中
Zheng Quan Shi Bao Wang· 2025-09-24 04:56
Group 1 - The core point of the article is that Wan'an Technology has seen a continuous decline in the number of shareholders, with a decrease of 3,390 shareholders, representing a 7.38% drop compared to the previous period [2] - As of September 20, the total number of shareholders is 42,556, marking the eighth consecutive period of decline [2] - The latest stock price of Wan'an Technology is 15.35 yuan, down 0.13%, but the stock has increased by 4.07% since the concentration of chips began [2] Group 2 - The margin trading data shows that as of September 23, the total margin balance is 324 million yuan, with a financing balance of 324 million yuan, reflecting an increase of 16.89 million yuan, or 5.51%, during the current period of chip concentration [2] - The company's semi-annual report indicates that for the first half of the year, it achieved operating revenue of 2.165 billion yuan, a year-on-year increase of 14.91%, while net profit was 85.1783 million yuan, a year-on-year decrease of 2.13% [2] - The basic earnings per share are 0.1600 yuan, and the weighted average return on net assets is 2.84% [2]
云南锗业最新股东户数环比下降6.67%
Zheng Quan Shi Bao Wang· 2025-09-24 02:35
Core Viewpoint - Yunnan Germanium Co., Ltd. has experienced a decrease in the number of shareholders for the second consecutive period, indicating a potential shift in investor sentiment [2]. Group 1: Shareholder Information - As of September 20, the number of shareholders for Yunnan Germanium was 111,660, a decrease of 7,985 from the previous period (September 10), representing a 6.67% decline [2]. - This marks the second consecutive period of decline in the number of shareholders [2]. Group 2: Stock Performance - The latest stock price for Yunnan Germanium is 27.76 yuan, reflecting a slight increase of 0.11%. Since the concentration of shares began, the stock has risen by a cumulative 1.50% [2]. - The stock experienced 6 days of increases and 4 days of decreases during this period [2]. Group 3: Financing and Margin Data - As of September 23, the total margin balance for the stock was 1.552 billion yuan, with a financing balance of 1.541 billion yuan. The financing balance has increased by 161 million yuan, or 11.66%, since the concentration of shares began [2]. Group 4: Financial Performance - In the first half of the year, Yunnan Germanium achieved operating revenue of 529 million yuan, a year-on-year increase of 52.10%. The net profit reached 22.1498 million yuan, representing a significant year-on-year growth of 339.60% [2]. - The basic earnings per share were 0.0340 yuan, and the weighted average return on net assets was 1.51% [2].
海翔药业最新筹码趋于集中
Zheng Quan Shi Bao Wang· 2025-09-24 02:12
Summary of Key Points Core Viewpoint - Haisheng Pharmaceutical has experienced a decline in the number of shareholders and a decrease in stock price, indicating potential challenges in its financial performance and investor sentiment [2]. Group 1: Shareholder and Stock Performance - As of September 20, the number of shareholders for Haisheng Pharmaceutical was 26,641, a decrease of 2,277 from the previous period (September 10), representing a decline of 7.87% [2]. - The latest stock price for Haisheng Pharmaceutical is 5.88 yuan, remaining flat, with a cumulative decline of 8.13% since the concentration of shares began [2]. - The stock has seen 3 days of increases and 6 days of decreases during this period [2]. Group 2: Financing and Margin Data - As of September 23, the margin trading balance for the stock was 866 million yuan, with a financing balance of 865 million yuan [2]. - The financing balance has decreased by 2.8457 million yuan, reflecting a decline of 0.33% since the concentration of shares began [2]. Group 3: Financial Performance - In the first half of the year, Haisheng Pharmaceutical reported total revenue of 925 million yuan, a year-on-year decrease of 10.94% [2]. - The net profit for the same period was 14.0937 million yuan, down 63.01% year-on-year [2]. - The basic earnings per share were 0.0100 yuan, with a weighted average return on equity of 0.27% [2].
唯万密封最新筹码趋于集中
Zheng Quan Shi Bao Wang· 2025-09-24 02:10
Summary of Key Points Core Viewpoint - Weiman Sealing reported a decrease in the number of shareholders and a slight decline in stock price, despite a significant increase in revenue and net profit in the first half of the year [2]. Shareholder and Stock Performance - As of September 20, the number of shareholders for Weiman Sealing was 12,804, a decrease of 1,770 shareholders compared to the previous period, representing a decline of 12.14% [2]. - The latest stock price for Weiman Sealing is 40.58 yuan, down 3.03%, but the stock has increased by 12.91% since the concentration of shares began [2]. - Over the past trading days, the stock experienced 5 days of increases and 5 days of decreases [2]. Financing and Margin Data - As of September 23, the margin balance for the stock was 166 million yuan, with the financing balance also at 166 million yuan. The financing balance has decreased by 16.6371 million yuan, a decline of 9.09% since the concentration of shares began [2]. Financial Performance - In the first half of the year, Weiman Sealing achieved operating revenue of 386 million yuan, a year-on-year increase of 16.27%. The net profit was 48.0231 million yuan, reflecting a year-on-year growth of 22.64%. The basic earnings per share were 0.4000 yuan, and the weighted average return on equity was 4.88% [2]. Institutional Ratings - In the past month, Weiman Sealing received buy ratings from two institutions. The highest target price was set by Guosen Securities at 44.45 yuan, as reported on September 7 [2].
震裕科技最新股东户数环比下降8.56% 筹码趋向集中
Zheng Quan Shi Bao Wang· 2025-09-24 02:10
Group 1 - The core point of the article is that Zhenyu Technology has seen a significant decrease in the number of shareholders, with a reduction of 2,027 accounts, representing a decline of 8.56% compared to the previous period [2] - As of September 23, the stock's margin balance is reported at 847 million yuan, with a financing balance of 844 million yuan, indicating an increase of 81.52 million yuan or 10.70% during the current concentration period [2] - The company reported a revenue of 4.047 billion yuan for the first half of the year, reflecting a year-on-year growth of 29.17%, and a net profit of 211 million yuan, which is a 60.45% increase year-on-year [2] Group 2 - The latest stock price of Zhenyu Technology is 161.82 yuan, showing a slight decline of 0.32%, but the stock has increased by 8.68% since the concentration of shares began [2] - In the past month, six institutions have given a buy rating for the stock, with the highest target price set at 168.00 yuan by CICC on August 29 [2]
23股最新股东户数降逾一成 93股筹码连续集中3期以上
Xin Lang Cai Jing· 2025-09-24 00:44
Group 1 - A total of 501 stocks reported their shareholder numbers as of September 20, with 282 stocks showing a decrease in shareholder count compared to the previous period (September 10) [1] - Among the stocks with a significant decline, 23 stocks experienced a drop of over 10% in shareholder numbers [1] - The stock with the largest decrease in shareholder count is Kaichuang Electric, which reported 6,101 circulating shareholders, a decline of 27.34% from September 10 [1] Group 2 - Over a longer time frame, 93 stocks have seen their shareholder numbers decrease for more than three consecutive periods, indicating a trend of increasing concentration of shares [1] - Some stocks have experienced a continuous decline in shareholder numbers for as many as 13 periods [1]
筹码新动向:283股筹码趋向集中
Zheng Quan Shi Bao Wang· 2025-09-23 09:41
Summary of Key Points Core Viewpoint - A total of 501 stocks reported their latest shareholder numbers as of September 20, with 283 stocks showing a decline in shareholder numbers compared to the previous period, indicating a trend of decreasing investor interest in certain stocks [1][4]. Group 1: Shareholder Numbers - Among the 501 stocks, 21 stocks experienced a decline of over 10% in shareholder numbers, with the largest drop being 27.34% for Kaichuang Electric, which had 6,101 shareholders as of September 20 [4]. - The second largest decline was for Dalian Technology, which saw a 23.68% decrease, bringing its shareholder count to 22,629 [4]. - Other notable declines included Yuanlong Yatu (20.44%), Changjiang Materials (16.51%), and Zhonglun New Materials (16.32%) [4]. Group 2: Stock Performance - The average decline for concentrated stocks since September 1 was 2.94%, underperforming the Shanghai Composite Index, which fell by 0.94% during the same period [2]. - Among the concentrated stocks, 31% outperformed the market, indicating that some stocks managed to provide excess returns despite the overall downturn [2]. - Notable performers included Dingxin Communications, which rose by 25.62%, and Jinkong Coal, which increased by 15.62% [2]. Group 3: Industry Concentration - The concentrated stocks were primarily found in the basic chemical, mechanical equipment, and pharmaceutical industries, with 33, 30, and 27 stocks respectively [4]. - The trend of decreasing shareholder numbers and stock performance varies significantly across different industries, highlighting the importance of sector analysis in investment decisions [4].